Nilsine Partners, LLC Gilead Sciences, Inc. Transaction History

Nilsine Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 22, 2024	BUY	$71.58 - $87.29 $56,548 - $68,959	790 Added 6.36%	13,216 $968 Million
Q4 2023 Jan 24, 2024	BUY	$73.27 - $83.09 $38,979 - $44,203	532 Added 4.47%	12,426 $1.01 Billion
Q3 2023 Nov 01, 2023	BUY	$73.94 - $80.67 $9,390 - $10,245	127 Added 1.08%	11,894 $891 Million
Q2 2023 Jul 21, 2023	BUY	$76.01 - $86.7 $2,280 - $2,601	30 Added 0.26%	11,767 $907 Million
Q1 2023 May 10, 2023	BUY	$77.31 - $88.08 $907,387 - $1.03 Million	11,737 New	11,737 $974 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Nilsine Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Nilsine Partners, LLC with notifications on news.